Cerebral palsy nursing: assessment, interventions, and NCLEX review

Cerebral palsy (CP) is the most common cause of childhood physical disability, affecting approximately 1.5–4 per 1,000 live births worldwide. It describes a group of permanent, non-progressive movement and posture disorders caused by a static lesion in the developing brain — most often occurring prenatally, perinatally, or within the first two years of life. The brain injury itself does not worsen over time, but the functional consequences change as the child grows.

For nurses and nursing students, CP is clinically important and NCLEX-relevant. Acute care encounters are common: aspiration pneumonia, seizures, surgical care for spasticity, and hip surgery all bring children with CP to hospital settings. Understanding CP type, functional classification, and associated conditions drives safe nursing care — from positioning during feeds, to intrathecal baclofen pump monitoring, to pain assessment in a non-verbal child.

This reference covers the full clinical picture: etiology and pathophysiology, the two major classification systems (motor type and GMFCS), clinical presentation, nursing assessment and interventions, spasticity management, complications to monitor, and family teaching priorities. Twelve NCLEX high-yield tips are provided at the end.

CP at a glance

Pathophysiology and etiology

CP results from a static (non-worsening) injury to the immature central nervous system during a period of active brain development. The injury disrupts cortical motor control pathways — primarily the corticospinal tract — producing the characteristic movement and posture abnormalities. Because the lesion is fixed, the underlying neuropathology does not progress. However, secondary musculoskeletal consequences (contractures, hip subluxation, scoliosis) do develop over time in response to abnormal muscle tone and disuse.

Timing of injury

The brain is vulnerable to injury across three developmental windows:

Prenatal (before 28 weeks gestation in many cases): Cortical maldevelopment, periventricular leukomalacia from preterm birth, congenital infection (cytomegalovirus, toxoplasmosis, rubella), stroke, and genetic or metabolic disorders. Prenatal causes account for approximately 70–80% of CP cases.

Perinatal (around the time of birth): Hypoxic-ischemic encephalopathy (HIE) in term infants is the classic perinatal cause — reduced cerebral perfusion during labour and delivery triggers a cascade of neuronal injury. Therapeutic hypothermia (initiated within 6 hours of birth for moderate-to-severe HIE) has reduced the rate of CP attributable to HIE, but not eliminated it.

Postnatal (first 2 years of life): Meningitis or encephalitis, hypoglycaemia, near-drowning, head trauma, and stroke can all produce acquired CP. This category accounts for roughly 10–15% of cases.

Risk factors

Prematurity is the single strongest risk factor for CP. Infants born before 28 weeks gestation have a CP rate approximately 40–100 times higher than term infants, primarily due to periventricular white matter injury. Other significant risk factors include:

• Multiple gestation (twins, triplets)
• Intrauterine growth restriction
• Maternal infection or chorioamnionitis
• Neonatal stroke
• Severe neonatal hypoglycaemia
• Postnatal CNS infection

Classification systems

CP is classified by two independent systems that together describe the clinical picture: motor type (what kind of movement disorder) and functional level (what the child can actually do). Both are used in clinical practice and appear in NCLEX content.

Motor type classification

Spastic diplegia is the subtype most strongly associated with preterm birth and periventricular leukomalacia. The characteristic presentation is bilateral lower-limb spasticity producing the classic scissors gait (adductor hypertonicity causes knees and thighs to cross during walking). Upper limbs are relatively spared.

Spastic hemiplegia involves one side of the body (arm more than leg) and is most often caused by unilateral cortical or subcortical injury — stroke, periventricular hemorrhagic infarction, or congenital brain malformation. Seizure risk is highest in spastic hemiplegia (~50%).

Spastic quadriplegia is the most severe form. All four limbs are involved, oral-motor function is significantly impaired (dysphagia, dysarthria), and cognitive disability and seizures are common.

GMFCS — Gross Motor Function Classification System

The GMFCS describes what a child with CP can do, not what’s wrong neurologically. It has five levels based on self-initiated movement with emphasis on sitting, walking, and wheeled mobility. Levels are age-specific (best descriptions available for 6–12 years):

GMFCS level is the strongest predictor of hip subluxation risk — children at levels IV and V have up to 90% risk of hip displacement without surveillance and intervention.

Clinical presentation

Motor and developmental features

The presenting signs of CP depend on type, but certain features are common across subtypes:

Developmental motor delays are typically the first concern. Infants may not roll by 4–6 months, sit independently by 9 months, or pull to stand by 12 months. Asymmetric motor development — consistent hand preference before age 18 months (which implies hemiplegia) — is an early red flag.

Abnormal muscle tone varies by type: spastic CP produces velocity-dependent hypertonia (resistance increases with the speed of passive stretch — the classic “clasp-knife” response), while dyskinetic CP fluctuates between hypotonia and dystonia, and ataxic CP presents with hypotonia.

Primitive reflex persistence is a hallmark of upper motor neuron injury. Normally, the Moro reflex disappears by 4–6 months and the asymmetric tonic neck reflex (ATNR) by 6 months. In CP, persistence beyond these ages is a red flag. The ATNR (“fencing reflex”) — triggered by head rotation, causing extension of the limbs on the face side and flexion on the skull side — significantly impairs feeding and voluntary arm use when it persists.

Upper motor neuron signs in spastic CP: hyperreflexia, clonus, Babinski sign (extensor plantar response), and spasticity. This is the clinical distinction from lower motor neuron conditions such as muscular dystrophy (see spinal cord injury nursing for an upper vs lower motor neuron comparison).

Associated conditions

Most children with CP have at least one co-occurring condition, and many have several:

Nursing assessment

Functional assessment tools

Gross Motor Function Classification System (GMFCS) — five-level scale of gross motor function based on age-appropriate motor tasks. Used to predict trajectory, guide therapy goals, and stratify orthopaedic screening intervals.

Manual Ability Classification System (MACS) — five-level scale for how children with CP use their hands in daily activities. Complements GMFCS and informs OT goals and equipment planning.

Communication Function Classification System (CFCS) — five levels of effective communication, from independent with unfamiliar partners (Level I) to seldom effective even with familiar partners (Level V).

Nutritional assessment

Growth failure is common in moderate-to-severe CP. Contributing factors include dysphagia (increased effort and time per feed), high energy expenditure from involuntary movements (dystonia), oral-motor dysfunction limiting intake, and frequent GI complications (reflux, constipation). Assessment includes:

• Weight, height/length, and head circumference plotted on CP-specific growth charts where available
• Skinfold thickness measurements (BMI is less reliable given altered body composition in non-ambulatory children)
• Feeding observation — meal duration, texture tolerance, choking frequency, wet voice after eating
• Referral to dietitian and SLP for dysphagia evaluation (videofluoroscopic swallow study or FEES) when aspiration risk is suspected

Pain assessment

Pain is highly prevalent in CP and is frequently undertreated, partly because many affected children cannot reliably self-report. Nurses must use validated observational tools rather than relying on verbal pain rating scales.

The FLACC scale (Face, Legs, Activity, Cry, Consolability) is the most commonly used observational pain scale for children who cannot self-report. Each domain is scored 0–2; total scores 0–10. A FLACC score ≥4 indicates moderate pain requiring intervention. The revised FLACC (r-FLACC) includes descriptors tailored to children with cognitive impairment.

Other validated tools include the Pediatric Pain Profile (PPP) and Non-Communicating Children’s Pain Checklist (NCCPC).

Skin integrity assessment

Spasticity creates sustained, high-pressure contact between bony prominences and seating or support surfaces — particularly the ischial tuberosities, sacrum, heels, and ankles. Children in GMFCS IV–V who spend extended time in a wheelchair or lying down are at significant pressure injury risk. See wound assessment for full Braden Scale and staging guidance.

Assessment priorities:

• Daily skin inspection at all bony prominences and under orthotic devices (AFOs, TLSO braces)
• Orthotic fit — check for redness, skin breakdown, or maceration at brace edges
• Moisture management — urinary incontinence is common and must be managed proactively
• Positioning — assess for sustained postures that increase shear or pressure

Respiratory assessment

Aspiration pneumonia is the leading cause of death in individuals with severe CP. Respiratory nursing assessment includes:

• Breath sounds for crackles, wheezing, or absent sounds suggesting consolidation
• Respiratory rate and work of breathing
• Oxygen saturation (baseline SpO2 and trend)
• Cough effectiveness — in spastic quadriplegia, weak cough increases secretion retention risk
• Feeding history — frequency of choking, coughing, gagging, or desaturation during feeds

Nursing interventions

Medical and surgical management

Spasticity management

Spasticity is the most common target of medical intervention in CP. The goal is to reduce tone enough to improve function, comfort, and care — not to eliminate tone, since some residual tone supports upright posture and ambulation in many children.

Oral medications:

• Baclofen (oral): GABA-B agonist that reduces spinal reflex activity. Side effects include sedation, hypotonia, and drowsiness. Dosing requires gradual titration. Part of the drug classifications group with significant CNS effects.
• Diazepam: Benzodiazepine with central GABA-A activity. Useful for acute spasticity or dystonic crisis. Sedation and tolerance limit long-term use.
• Tizanidine: Alpha-2 agonist; alternative to baclofen. Monitor for hepatotoxicity (LFTs at baseline and during therapy).
• Dantrolene: Acts directly on muscle by reducing calcium release from the sarcoplasmic reticulum. Hepatotoxicity risk; used mainly when other agents fail.

Intrathecal baclofen (ITB) therapy:

An intrathecal pump delivers baclofen directly into the cerebrospinal fluid via a programmable implanted device, achieving significantly higher CSF concentrations than oral dosing allows. ITB is used for children with severe generalized spasticity or dystonia who do not respond to or tolerate oral agents.

Nursing priorities specific to ITB:

• Monitor pump site for swelling, redness, or CSF leak (catheter dislodgement)
• Know the signs of baclofen withdrawal (pump failure, empty reservoir, catheter kink): escalating spasticity, hyperthermia, altered mental status, seizures, rhabdomyolysis — a life-threatening emergency
• Know the signs of baclofen overdose (programming error, concentration error): profound hypotonia, respiratory depression, loss of consciousness — requires ICU-level support
• Report any sudden change in tone — either increased spasticity or new hypotonia — as a potential pump malfunction
• Pump must be refilled at scheduled intervals (typically every 1–6 months); missed appointments can result in unexpected withdrawal

Botulinum toxin A (Botox) injections:

Injected directly into spastic muscles, BTX-A blocks acetylcholine release at the neuromuscular junction, producing localized temporary weakness lasting 3–6 months. Used for focal spasticity (a spastic gastrocnemius or hip adductors, for example) to delay or avoid surgery, improve gait, and facilitate stretching. Does not cure spasticity; repeated injections are required. Effect is localized — does not cross to adjacent muscle groups in therapeutic doses.

Orthopedic surgery

Surgical management addresses fixed contractures, hip instability, and scoliosis that cannot be managed conservatively:

• Selective dorsal rhizotomy (SDR): Permanent spasticity reduction via partial sectioning of sensory nerve rootlets in the spinal cord. Reserved for selected ambulatory children with spastic diplegia. Requires intensive post-operative physical therapy.
• Tendon lengthening / release: Addresses fixed contractures of the Achilles tendon, hip flexors, hamstrings, or hip adductors. Improves gait mechanics and positioning.
• Hip reconstruction / stabilization: Indicated for subluxation or dislocation detected on surveillance X-rays (GMFCS IV–V). Earlier intervention prevents pain and severe deformity.
• Scoliosis surgery (spinal fusion): For progressive curves causing respiratory compromise or positioning difficulties — most often in non-ambulatory children.

Assistive equipment and therapy coordination

• Ankle-foot orthoses (AFOs): Maintain foot/ankle alignment, facilitate standing and gait
• Wheelchairs and adaptive seating: Custom postural support for non-ambulatory children; power chairs for children with sufficient cognitive and upper-limb function
• Augmentative and alternative communication (AAC) devices: Eye-gaze, switch-access, and VOCA devices for non-speaking children
• PT, OT, SLP: Ongoing therapy across the lifespan is foundational to maximizing function. Nurses coordinate with these disciplines and carry therapy strategies into daily care — positioning, feeding techniques, communication supports.

Complications the nurse must monitor

Family education and discharge teaching

Most children with CP are discharged to home care managed predominantly by parents and caregivers. Discharge teaching should be practical, demonstrated rather than just described, and offered in multiple formats.

Home safety and positioning

• Demonstrate safe transfer techniques and positioning in supported seating
• Advise on modifications to reduce fall risk (padding on furniture corners, non-slip mats, grab bars)
• Teach correct application, removal, and skin inspection for all orthotics — family members should demonstrate return of technique before discharge
• Instruct on proper wheelchair positioning: pelvis level, hips and knees at 90°, feet supported, trunk supported to prevent lateral lean

Feeding and aspiration prevention

• Reinforce positioning for feeds: upright (or slightly forward), never reclined
• Review texture modifications as prescribed by SLP — demonstrate thickening techniques
• Identify signs of aspiration: color change, coughing or choking during or after meals, wet or gurgly voice, recurrent chest infections
• Gastrostomy tube care if applicable: site care, feed administration, troubleshooting

Seizure action plan

Families of children with epilepsy must leave with a written seizure action plan. Teach:

• What a seizure looks like for their child (semiology may differ from textbook descriptions)
• When to use rescue medication (midazolam buccal or intranasal, diazepam rectal gel)
• When to call 911 (seizure >5 minutes, repeated seizures, failure to recover, respiratory compromise)
• Safety during a seizure: do not restrain, protect head, turn to side after convulsive phase, do not put anything in mouth

For nursing students, the full seizure management protocol is in the seizure nursing reference.

Medication adherence

• Emphasize that antispasticity medications and antiepileptics must never be stopped abruptly
• For baclofen (especially oral): abrupt discontinuation causes hallucinations, seizures, and autonomic instability
• Intrathecal baclofen pump: stress the importance of scheduled refill appointments; explain that running dry causes a potentially fatal withdrawal syndrome
• Provide written medication schedule; review signs of side effects and when to contact the prescriber

School and community resources

• Early Intervention programs (under age 3, funded under IDEA Part C in the United States)
• Special education services from age 3 under IDEA Part B
• Disability-specific support organizations (United Cerebral Palsy, state-based CP foundations)
• Respite care services — families of children with severe CP carry enormous care burdens; proactive referral to respite services reduces caregiver burnout

Caregiver burnout recognition

Research consistently shows that parents of children with severe CP experience rates of depression, anxiety, and burnout significantly higher than the general population. Before discharge:

• Screen with validated tool (PSI-Short Form or simple open questions about sleep, emotional wellbeing)
• Provide community mental health referrals where indicated
• Normalize the need for help — frame respite and support services as part of the child’s care plan, not a parenting failure

NCLEX high-yield tips

1. Spastic CP is the most common type (70–80% of all CP). Within spastic CP, diplegia is the most common subtype and is strongly associated with preterm birth and periventricular leukomalacia.

2. Scissors gait = spastic diplegia. Hip adductor spasticity causes the thighs to cross during walking. This is one of the most commonly tested clinical presentations.

3. GMFCS I = walks without restrictions; GMFCS V = no independent mobility. Know the five levels conceptually — questions often present a clinical scenario and ask the nurse to identify functional level or appropriate interventions.

4. CP is non-progressive. The brain lesion is static and does not worsen. Functional decline that appears as the child grows reflects increasing physical demands relative to fixed neurological capacity — not new brain injury.

5. Pain assessment in non-verbal CP uses the FLACC scale (or r-FLACC). Do not rely on self-report. Behavioral agitation is often a sign of undertreated pain; investigate before attributing it to behavior.

6. Primitive reflex persistence is a red flag. Moro reflex should disappear by 4–6 months; ATNR by 6 months. Persistence suggests upper motor neuron dysfunction consistent with CP.

7. Aspiration risk: position at 90° upright for all oral feeds. Use thickened liquids as prescribed by SLP. The tongue thrust reflex and oral hypotonia common in CP impair the pharyngeal phase of swallowing.

8. Intrathecal baclofen pump failure = life-threatening withdrawal. Escalating spasticity, hyperthermia, altered consciousness, and seizures after a sudden change in tone suggest pump failure or empty reservoir. This is a medical emergency. Oral or IV baclofen must be sourced immediately.

9. Botulinum toxin A injections: temporary (3–6 months), localized, not curative. Botox reduces focal spasticity by blocking ACh at the neuromuscular junction. Repeated injections are required. It does not treat the underlying condition.

10. HIE is a major cause of CP in term infants. Questions linking hypoxic-ischemic encephalopathy to later CP diagnosis are common. Therapeutic hypothermia reduces but does not eliminate CP risk.

11. Hip subluxation is the most common orthopaedic complication in non-ambulatory CP. Children at GMFCS IV–V require annual hip X-rays for surveillance. Limited hip abduction on physical exam is an early sign.

12. Seizures occur in ~35% of people with CP, most commonly in spastic hemiplegia. Nursing management includes antiepileptic medication administration, seizure precautions, and documentation of seizure characteristics. Full protocol in the seizure nursing reference.

13. CP (UMN) vs muscular dystrophy (LMN): CP produces upper motor neuron signs — hyperreflexia, spasticity, Babinski sign, clonus. Muscular dystrophy produces lower motor neuron/muscle signs — hyporeflexia, progressive weakness, Gowers sign, muscle pseudohypertrophy. This distinction appears on NCLEX. See spinal cord injury nursing for an upper vs lower motor neuron sign comparison.

14. Oral baclofen must never be stopped abruptly. Withdrawal causes hallucinations, fever, and seizures. This mirrors intrathecal baclofen withdrawal but is less severe and not immediately life-threatening. Review medication education before discharge.

For foundational pediatric nursing context, see the pediatric nursing reference. For the neonatal period and HIE — the leading perinatal cause of CP — see the neonatal HIE nursing reference and the neonatal nursing reference.